Latest Tumor suppressor genes Stories
First major service extension to the company's BRCAvantage(TM) BRCA1 and BRCA2 mutation test menu offers screening for five new non-BRCA genes shown to increase risk of inherited breast cancer MADISON,
HealthForumOnline (HFO) has recently updated The Psychosocial Needs of Women Undergoing Genetic Counseling and Testing in the Breast Cancer Context, an online continuing education (CE) course
The VHL Alliance awards $125,000 in grant money to fund two unique research projects that will make great headways into finding a cure for cancer. Boston, MA
Angelina Jolie’s decision to have a double mastectomy after being told she would likely develop breast cancer had a tremendous impact on testing for the disease in the UK, the authors of a new Breast Cancer Journal study reported on Friday.
GILBERT, Ariz., Aug.
Women with mutations in the PALB2 gene have on average a one in three chance of developing breast cancer by the age of seventy.
CHARGE, which affects 1 in 10,000 babies, is an acronym whose letters stand for some of the more common symptoms of the condition: coloboma of the eye, heart defects, atresia of the choanae, retardation of growth and/or development, genital and/or urinary abnormalities, and ear abnormalities and deafness.
Although mutations in a gene dubbed "the guardian of the genome" are widely recognized as being associated with more aggressive forms of cancer, researchers at the University of California, San Diego School of Medicine have found evidence suggesting that the deleterious health effects of the mutated gene may in large part be due to other genetic abnormalities, at least in squamous cell head and neck cancers.
- Trial will measure investigational compound's efficacy and safety in patients with HER2-negative breast cancer, associated with BRCA 1, BRCA 2 mutations NORTH CHICAGO, Ill.,
- Growing in low tufty patches.